AstraZeneca executives try to shift I-O focus with China, Brilinta wins
admin 9th November 2017 Uncategorised 0You know executives are over the immuno-oncology questions when one of them offers to hand out a bottle of champagne to the first person to ask a question about cardiovascular, metabolic or respiratory medicines. And that’s what happened 58 minutes into AstraZeneca’s third-quarter earnings call.
More: AstraZeneca executives try to shift I-O focus with China, Brilinta wins
Source: fierce